Arch Capital Group is a Bermuda-based specialty insurer that underwrites risk across three engines: primary specialty property & casualty insurance, global reinsurance, and — unusually for a P&C name — U.S. and international mortgage insurance. Its core business is pricing hard-to-underwrite risk and collecting premium today against claims paid years later, then earning investment income on the float in between. What sets Arch apart is a decade-plus record of disciplined, cycle-aware underwriting — it leans into lines when pricing is rich and pulls back when it softens — which has produced a combined ratio in the low-80s (well under the 100% underwriting-profit line) and mid-to-high-teens returns on equity. It pays no regular common dividend, instead compounding book value per share and returning capital through large, opportunistic share buybacks. For a reader, think of it as one of the best-run specialty underwriters in the world, with a mortgage-insurance arm that is a genuine differentiator among P&C peers.
Lifecycle: Mature, best-in-class specialty insurer. Scored on insurance metrics — combined ratio, ROE, book-value growth, reserve quality, investment income — not industrial revenue/margin/FCF, which are structurally misleading for an insurer (premium is collected first, claims paid years later; “revenue” mixes premium, investment and other income).
| Sub-signal | Reading | Score |
|---|---|---|
| Combined ratio | 80.8% FY2025, 81.7% Q1'26 — deep underwriting profit (<95% is strong). NB: Q1 flattered by a $200m favourable reserve release + benign CATs | 92 |
| ROE | ~17% operating (17.1% FY25 op, 15.4% Q1'26 op, 17.8% Q1'26 net) — >15% is exceptional for a P&C name | 86 |
| Book-value-per-share growth | BVPS $66.19 at Mar-2026, +1.7% in the quarter after $783m of buybacks — compounding despite shrinking share count | 85 |
| Balance sheet / reserves | Debt/equity 0.11x, interest coverage 36x, A-rated; reserves adequate with modest favourable development | 84 |
| Diversification of earnings | Three engines — Insurance, Reinsurance ($1.6bn u/w income FY25), Mortgage ($1bn, 4th straight year >$1bn) — smooths any single cycle | 80 |
Moat average ≈ 64 — the durable edge is underwriting discipline + a differentiated mortgage arm + a bottom-quartile expense base, not lock-in. Switching-cost and pricing sub-scores are held down by the competitive, well-capitalised specialty market (see Competitive Environment).
| Rival | Threat type | Share trajectory | Moat-erosion vector |
|---|---|---|---|
| RenaissanceRe (RNR), Everest (EG) | Reinsurance capacity peers | Stable | Abundant reinsurance capital is softening property-cat pricing off the 2023-24 highs — pressures Pricing Power |
| W.R. Berkley (WRB), Markel (MKL), Chubb (CB) | Specialty P&C rivals | Stable / Arch modestly gaining in select lines | Competes on underwriting appetite; well-run peers cap pricing upside |
| MGIC, Essent, Radian | Mortgage-insurance rivals | Stable | MI is an oligopoly; the risk is the housing/credit cycle, not share loss — earnings near cycle highs |
Net effect on moat: a competitive, capital-rich specialty market → Switching Costs held to 58, Pricing Power to 70; Cost Advantage (72) intact. Overall competitive_threat_level = moderate, share trajectory stable. Feeds the §11 Bear (P&C rate softening + mortgage-cycle) and §12 thesis-invalidation.
Capital allocation / management: exemplary — buys back stock opportunistically ($783m Q1'26), grows BVPS through the cycle, no value-destructive M&A. FMP financial-health rating A (5/5 on ROE and DCF). New CEOs promoted internally in Reinsurance and Mortgage (Jun 2026) — continuity, not a shake-up.
Valuation lens = P/Book / P/TBV, never P/E as the primary. Insurer earnings are volatile from reserves and investment marks, so book value is the honest anchor.
| Lens | Reading | Signal |
|---|---|---|
| P/TBV (primary) | 1.70x actual vs 3.0x warranted | Attractive |
| P/Book (GAAP) | 1.49x on $67.25 BVPS | Cheap |
| Trailing P/E | 7.6x — but CYCLE-FLATTERED (peak underwriting + reserve release); a secondary, treat with care | Cheap (flattered) |
| Forward P/E | ~10.8x on FY26E EPS $9.30 — the cleaner earnings read; still cheap for the quality | Attractive |
| Analyst consensus target | $111.4 consensus / $105 median vs $100.04 → ~+11% to consensus; 19 firms with price targets; grades 16 Buy / 16 Hold / 2 Sell (34 grade-actions) | Modest upside |
| Capital return | No common dividend — returns capital via buybacks (BVPS-accretive at 1.5-1.7x TBV) | Buyback, not yield |
Primary driver: the balance of the catastrophe-loss / underwriting-pricing cycle against investment yields on the float. Secondary: the P&C pricing cycle and the housing/mortgage cycle (for the MI arm).
| Horizon | Read | Label |
|---|---|---|
| Short (0-3m) | Investment income tailwind is live (10Y ~4.5%, higher-for-longer reinvests the float at attractive yields), but property-cat + P&C pricing is softening off the 2023-24 hard-market peak. Net balanced. | Neutral (58) |
| Medium (6-12m) | Higher-for-longer keeps float income strong; offset by a maturing underwriting cycle and mortgage earnings at cycle highs. A genuine tailwind but not a slam-dunk. | Neutral (60) |
| Long (3-5y) | Durable compounder; float income normalises if rates eventually fall, underwriting cycle turns. Quality carries it, driver neutral. | Neutral (62) |
Amplification: driver ≈ 60 sits in the 36-64 Neutral band — NOT eligible to amplify. This is the honest call: the investment-income tailwind is real, but the underwriting/CAT cycle is at or past its peak and P&C rates are softening, so we do not manufacture a Medium STRONG BUY. Base BUY/HOLD stands unchanged at every horizon.
Latest macro report: XLF Short O / Medium O / Long N. Higher-for-longer rates lift insurer float/investment income and real+fast money is flowing into Financials — a Medium-horizon Tailwind. The signal fades to Neutral at the Long horizon (XLF Long = N), so the pressure is Tailwind (Short/Med) softening to Neutral (Long). Trend-Following: going long ACGL rides the Financials tailwind. Pressure enabled NO amplification here because the Underlying Driver (60) did not clear 65 — both conditions must hold, so Medium stays BUY, not STRONG BUY.
Source: sector-map (GICS Financials → XLF) · Macro report 2026-07-14
Lead score 55/100 — Neutral. The stock is in a healthy primary uptrend but sits near the top of its range with no fresh, volume-confirmed trigger, and earnings are 12 days out.
| Element | Reading |
|---|---|
| MTF confluence | Monthly + weekly + daily all uptrend (daily strong_uptrend, price > SMA50 > SMA200); hourly rolled over to a short-term downtrend. Confluence “strongly_bullish” on the higher frames. |
| Risk-reward / position | Price ~$100 sits ~14% above weekly support ($82-87) — a wide stop, unfavourable entry location. Daily ATR ~$2.2. RSI ~53 (neutral, room either way). |
| Breakout confirmation | Daily volume 0.91x average — BELOW the >1.5x needed to confirm a breakout. No fresh trigger. |
| Relative strength | ACGL near 52-week highs, outperforming the tape on down days (per recent Zacks reads) — sector leadership intact. |
| Macro overlay (High sensitivity) | Financials = High macro sensitivity (macro weight 0.20). Rates tailwind supportive; no high-impact release inside 3 days. |
| Sentiment / grades | All-maintain (Wells Fargo/Morgan Stanley OW, UBS/Citi Buy, KBW/Mizuho/Cantor Neutral) — no revision momentum. Neutral. |
| Catalyst | Q2 earnings 28 Jul — one clean, well-understood catalyst. Calm calendar otherwise. |
Net: a good business in a good trend, but the near-term tape offers no discounted entry and a print is imminent — hence Neutral timing and the Short capped to HOLD (buy on confirmation).
| Date | Event | Impact | Forecast | Previous | Relevant? | Why |
|---|---|---|---|---|---|---|
| 2026-07-28 | ACGL Q2 Earnings | High (stock-specific) | EPS $2.45E; Rev $4.36bn | Q1 EPS $2.88 | ✅ Yes | The binary event for this name — combined ratio, reserve development, CAT load, buyback pace |
| 2026-07-29 | FOMC Rate Decision | High | Hold | Hold | ✅ Yes | Financials = rate-sensitive; higher-for-longer supports float income |
| Date | Event | Actual | Forecast | Surprise | Impact |
|---|---|---|---|---|---|
| 2026-07-16 | Retail Sales MoM (Jun) | 0.5% | 0.5% | inline | Low |
| 2026-07-16 | Initial Jobless Claims | 208k | 217k | -4.2% (strong labour) | Medium |
| 2026-07-15 | Core PPI YoY (Jun) | 4.7% | 5.2% | -9.6% (cooler) | Medium |
| 2026-07-16 | Pending Home Sales MoM (Jun) | -5.4% | -0.5% | big miss | Medium |
The one event that matters for ACGL is its own Q2 print on 28 Jul, with the FOMC the next day. Cooler PPI and a soft housing print (a mild watch-item for the mortgage arm) frame a benign but not risk-free macro tape. Financials carry High macro sensitivity, but no high-impact release falls inside the 3-day WAIT-override window, so no forced short override — the Short HOLD comes from the technical-confirmation cap, not the calendar.
| Timeframe | Trend | Direction | RSI | MACD | Key S/R | Breakout | Vol |
|---|---|---|---|---|---|---|---|
| Monthly | Uptrend | Bullish | 58 | +, above signal | S $72.85 / R $103.8 | Resistance breakout | 0.4x |
| Weekly | Uptrend | Bullish | 58 | +, rising | S $82.4 / R $103.4 | Resistance breakout | 0.6x |
| Daily | Strong uptrend | Bullish | 53 | +, flat | S $92.8 / R $105.1 | Resistance breakout | 0.9x |
| Hourly | Downtrend | Bearish | 49 | -, turning up | S $97.9 / R $103.3 | Support breakdown | — |
| 15-min | Recovering | Neutral | 62 | +, small | S $98.9 / R $100.3 | Resistance breakout | — |
| Confluence: Strongly bullish on higher timeframes, short-term consolidating · MTF Score 68 | |||||||
The monthly, weekly and daily charts are all in clean uptrends with price above the rising SMA50 and SMA200 — the primary trend is firmly up and near 52-week highs. The hourly frame has pulled back (a normal intraday breather), and daily breakout volume (0.91x) is unconvincing. Read: healthy uptrend, but no fresh volume-confirmed entry right here; a pullback toward the $92-95 daily support or a post-earnings continuation on volume would be the cleaner add.
ACGL ~6-month daily (schematic): primary uptrend intact, price near 52-week highs at $100, well above weekly support at $82-87.
P&C pricing holds firmer than feared, CAT load stays benign, float income compounds at higher-for-longer yields, mortgage stays >$1bn, and continued buybacks accrete BVPS toward ~$75. Re-rates to ~1.9x TBV / ~13x forward. A high-quality compounder doing what it does.
Mid-single-digit book-value-per-share growth plus buybacks, combined ratio drifts up modestly from the low-80s as the cycle softens, and a small re-rating toward the ~$111 analyst consensus. ~1.75x TBV. The probability-weighted centre of gravity.
The downside is cycle-driven, not solvency: an adverse-reserve-development quarter (the $200m Q1 release reverses), P&C rate softening lifts the combined ratio back toward the mid-90s, a heavy CAT season, and a housing/mortgage downturn dents the MI segment. De-rates toward ~1.35x TBV. This is the LIVE competitive/cycle risk — not a distant tail.
Forecast: Fundamental group is already MET (the name is cheap). The Technical group needs either a volume-confirmed reclaim of resistance (~$105 on >1.5x volume) or a pullback into $92-95 daily support with a higher low — either could arrive within ~2-4 weeks depending on the tape and the 28 Jul print. The Catalyst path opens on 28 Jul: a >+5% post-earnings continuation on a strong combined ratio would confirm a short entry. Because only the Fundamental group is met (1 of 3), conviction is Half-Size and the SHORT horizon is capped to HOLD until a technical or catalyst trigger fires.
Forecast: Stop unlikely in the next 4-6 weeks — $90 is ~10% below spot and below the 200-day. The thesis-invalidation triggers are cycle-driven and would build over quarters, watched at each print. Nearest live risk is the 28 Jul combined-ratio / reserve-development read.
Position sizing not computed — specify your portfolio allocation and role for sizing guidance.
{
"ticker": "ACGL",
"exchange": "NASDAQ",
"exchange_ticker": "NASDAQ:ACGL",
"isin": "BMG0450A1053",
"api_ticker": "ACGL",
"company": "Arch Capital Group Ltd.",
"currency": "USD",
"date": "2026-07-16",
"version": "v6",
"lifecycle_stage": "mature",
"price_at_rating": 100.04,
"signal_short": "HOLD",
"signal_medium": "BUY",
"signal_long": "BUY",
"primary_signal": "BUY",
"quality_score": 84,
"valuation_score": 80,
"timing_score": 55,
"driver_score": 60,
"economic_alignment_stance": "Trend-Following",
"economic_alignment_conviction": 62,
"economic_alignment_pressure": "Tailwind",
"economic_alignment_source": "sector-map",
"macro_report_date": "2026-07-14",
"overall_confidence": 55,
"val_multiple_basis": "P/TBV",
"warranted_multiple": 3.0,
"actual_multiple": 1.7,
"warranted_ratio": 0.57,
"val_band": "attractive",
"discount_rate_r": 0.09,
"risk_free_10y": 0.045,
"g_near": 0.06,
"g_term": 0.03,
"nonop_pct_of_net_income": 14,
"clean_pe": 10.8,
"clean_peg": null,
"combined_ratio": 81.7,
"roe": 17.0,
"fair_value_est": 112,
"stop_loss": 90,
"target_price": 110,
"scenario_base_target": 110,
"scenario_bull_target": 122,
"scenario_bear_target": 80,
"competitive_share_trajectory": "stable",
"competitive_threat_level": "moderate",
"hard_gate_state": "clear",
"entry_groups_met": 1,
"entry_conviction": "Half-Size",
"exit_groups_live": 0,
"exit_action": "Hold",
"short_entry_confirmed": false,
"short_cap_reason": "Fundamental group met only; Technical + Catalyst both unmet (daily vol 0.91x fails breakout, price far from support, earnings 28 Jul not yet reported). Short BUY capped to HOLD \u2014 buy on confirmation.",
"gates_triggered": [],
"do_not_buy_triggers": [],
"next_update_date": "2026-07-29",
"next_update_basis": "earnings 2026-07-28 +1d",
"analysis_status": "starting",
"finder_ticker": "ACGL",
"finder_exchange": "\ud83c\uddfa\ud83c\uddf8 NASDAQ"
}